BlackRock Amends Balchem Stake, Maintains Passive Investment
Ticker: BCPC · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 9326
| Field | Detail |
|---|---|
| Company | Balchem CORP (BCPC) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns Balchem stock, showing continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Balchem Corporation's common stock as of December 31, 2023. This filing, Amendment No. 3, updates their previous disclosures regarding their passive investment in Balchem. This matters to investors because BlackRock is a major institutional investor, and their continued, albeit passive, stake in Balchem suggests a long-term belief in the company's value, which can influence other investors' perceptions and potentially the stock's stability.
Why It Matters
This filing confirms BlackRock's ongoing significant, yet passive, ownership in Balchem, signaling institutional confidence that could reassure current and prospective shareholders.
Risk Assessment
Risk Level: low — This is a routine amendment by a large institutional investor, indicating no immediate change in investment strategy or significant risk to the company.
Analyst Insight
Investors should view this as a routine update from a large institutional holder, confirming BlackRock's continued, passive interest in Balchem. It doesn't signal any immediate buy or sell action but reinforces the idea that Balchem is a company with significant institutional backing.
Key Numbers
- 057665200 — CUSIP Number (identifies Balchem Corporation's Common Stock)
- 13d-1(b) — Rule Designation (indicates BlackRock is a passive institutional investor)
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Balchem Corporation (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A amendment
- Amendment No. 3 (dollar_amount) — the specific amendment number for this filing
Forward-Looking Statements
- BlackRock will maintain its passive investment in Balchem Corporation. (BlackRock Inc.) — high confidence, target: Next 12 months
- Balchem Corporation's stock will likely experience continued stability due to institutional backing. (Balchem Corporation) — medium confidence, target: Next 6 months
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., a major institutional investment manager.
What is the subject company whose securities are being reported?
The subject company is BALCHEM CORPORATION, identified by the CUSIP Number 057665200.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires filing of this statement was December 31, 2023.
Under which rule is this Schedule 13G/A filed?
This Schedule is filed under Rule 13d-1(b), which typically applies to institutional investors who hold more than 5% of a company's stock but do not intend to influence or control the company.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding BALCHEM CORP (BCPC).